Karnataka cancels 16 drug licenses, suspends 8 including Pfizer depot

Karnataka has taken stringent action against the circulation of fake drugs by cancelling 16 pharmaceutical licenses across the state. The move is part of a broader regulatory crackdown aimed at safeguarding public health and ensuring the authenticity of medicines in the supply chain.

In addition to the cancellations, authorities suspended eight more licenses, including that of a Pfizer depot. The action signals increased scrutiny of drug distribution networks and storage facilities operating within Karnataka.

Officials have intensified inspections following concerns over counterfeit medicines entering the market. The cancellations and suspensions are expected to tighten compliance norms for pharmaceutical distributors and depot operators in the region.